STANDSTILL AND BOARD NOMINATION AGREEMENTStandstill and Board Nomination Agreement • December 21st, 2009 • Valeant Pharmaceuticals International • Pharmaceutical preparations • Delaware
THIS STANDSTILL AND BOARD NOMINATION AGREEMENT (“Agreement”), dated as of December 17, 2009, is entered into by and between Valeant Pharmaceuticals International, a Delaware corporation (the “Company”), ValueAct Capital Master Fund, L.P., a British Virgin Islands limited partnership, VA Partners I, LLC, a Delaware limited liability company, ValueAct Capital Management, L.P., a Delaware limited partnership, ValueAct Capital Management, LLC, a Delaware limited liability company, ValueAct Holdings, L.P., a Delaware limited partnership, and ValueAct Holdings GP, LLC, a Delaware limited partnership (collectively, the “Stockholders”), and acknowledged and agreed to by Brandon B. Boze, as the initial Nominee (as defined below).
